Epigenetic principles and mechanisms underlying nervous system functions in health and disease

被引:207
作者
Mehler, Mark F. [1 ,2 ,3 ]
机构
[1] Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Dept Neurosci & Psychiat, Rose F Kennedy Ctr Res Intellectual & Dev Diabili, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Dept Behav Sci, Rose F Kennedy Ctr Res Intellectual & Dev Diabili, Bronx, NY 10461 USA
[3] Albert Einstein Coll Med, Einstein Canc Ctr, Bronx, NY 10461 USA
基金
美国国家卫生研究院;
关键词
Epigenetics; Chromatin remodeling; Non-coding RNAs; RNA and DNA editing; RNA regulatory networks; Nuclear architecture; Stem cell biology; Learning and memory; Neuropsychiatric diseases; Neurodevelopmental disorders; Neurodegenerative diseases; Neurooncology; Neuroimmunology; Cerebrovascular disorders; Environmental epigenomics; Pharmacoepigenomics;
D O I
10.1016/j.pneurobio.2008.10.001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Epigenetics and epigenomic medicine encompass a new science of brain and behavior that are already providing unique insights into the mechanisms underlying brain development, evolution, neuronal and network plasticity and homeostasis, senescence, the etiology of diverse neurological diseases and neural regenerative processes. Epigenetic mechanisms include DNA methylation, histone modifications, nucleosome repositioning, higher order chromatin remodeling, non-coding RNAs, and RNA and DNA editing. RNA is centrally involved in directing these processes, implying that the transcriptional state of the cell is the primary determinant of epigenetic memory. This transcriptional state can be modified not only by internal and external cues affecting gene expression and post-transcriptional processing, but also by RNA and DNA editing through activity-dependent intracellular transport and modulation of RNAs and RNA regulatory supercomplexes, and through trans-neuronal and systemic trafficking of functional RNA subclasses. These integrated processes promote dynamic reorganization of nuclear architecture and the genomic landscape to modulate functional gene and neural networks with complex temporal and spatial trajectories. Epigenetics represents the long sought after molecular interface mediating gene-environmental interactions during critical periods throughout the lifecycle. The discipline of environmental epigenomics has begun to identify combinatorial profiles of environmental stressors modulating the latency, initiation and progression of specific neurological disorders, and more selective disease biomarkers and graded molecular responses to emerging therapeutic interventions. Pharmacoepigenomic therapies will promote accelerated recovery of impaired and seemingly irrevocably lost cognitive, behavioral, sensorimotor functions through epigenetic reprogramming of endogenous regional neural stem cell fate decisions, targeted tissue remodeling and restoration of neural network integrity, plasticity and connectivity. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:305 / 341
页数:37
相关论文
共 582 条
[1]   Dynamic binding orientations direct activity of HIV reverse transcriptase [J].
Abbondanzieri, Elio A. ;
Bokinsky, Gregory ;
Rausch, Jason W. ;
Zhang, Jennifer X. ;
Le Grice, Stuart F. J. ;
Zhuang, Xiaowei .
NATURE, 2008, 453 (7192) :184-U2
[2]   Genetics and epigenetics in major psychiatric disorders - Dilemmas, achievements, applications, and future scope [J].
Abdolmaleky, HM ;
Thiagalingam, S ;
Wilcox, M .
AMERICAN JOURNAL OF PHARMACOGENOMICS, 2005, 5 (03) :149-160
[3]   Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders [J].
Abe, Ted ;
Zukin, R. Suzanne .
CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (01) :57-64
[4]   Sequence variants in SLITRK1 are associated with Tourette's syndrome [J].
Abelson, JF ;
Kwan, KY ;
O'Roak, BJ ;
Baek, DY ;
Stillman, AA ;
Morgan, TM ;
Mathews, CA ;
Pauls, DA ;
Rasin, MR ;
Gunel, M ;
Davis, NR ;
Ercan-Sencicek, AG ;
Guez, DH ;
Spertus, JA ;
Leckman, JF ;
Dure, LS ;
Kurlan, R ;
Singer, HS ;
Gilbert, DL ;
Farhi, A ;
Louvi, A ;
Lifton, RP ;
Sestan, N ;
State, MW .
SCIENCE, 2005, 310 (5746) :317-320
[5]   Polyglutamine expansion causes neurodegeneration by altering the neuronal differentiation program [J].
Abou-Sleymane, G ;
Chalmel, F ;
Helmlinger, D ;
Lardenois, A ;
Thibault, C ;
Weber, C ;
Mérienne, K ;
Mandel, JL ;
Poch, O ;
Devys, D ;
Trottier, Y .
HUMAN MOLECULAR GENETICS, 2006, 15 (05) :691-703
[6]   Adult neurogenesis: From precursors to network and physiology [J].
Abrous, DN ;
Koehl, M ;
Le Moal, M .
PHYSIOLOGICAL REVIEWS, 2005, 85 (02) :523-569
[7]   Heterogeneous dysregulation of microRNAs across the autism spectrum [J].
Abu-Elneel, Kawther ;
Liu, Tsunglin ;
Gazzaniga, Francesca S. ;
Nishimura, Yuhei ;
Wall, Dennis P. ;
Geschwind, Daniel H. ;
Lao, Kaiqin ;
Kosik, Kenneth S. .
NEUROGENETICS, 2008, 9 (03) :153-161
[8]   A novel mutation in JARID1C/SMCX in a patient with autism spectrum disorder (ASD) [J].
Adegbola, Abidemi ;
Gao, Hanlin ;
Sommer, Steve ;
Browning, Marsha .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2008, 146A (04) :505-511
[9]   Microarray analysis of ncRNA expression patterns in Caenorhabditis elegans after RNAi against snoRNA associated proteins [J].
Aftab, Muhammad Nauman ;
He, Housheng ;
Skogerbo, Geir ;
Chen, Runsheng .
BMC GENOMICS, 2008, 9 (1)
[10]   Regulation and epigenetic control of transcription at the nuclear periphery [J].
Ahmed, Sara ;
Brickner, Jason H. .
TRENDS IN GENETICS, 2007, 23 (08) :396-402